Wyeth Loses Bid For TRO On Generic Zosyn

Law360, New York (September 24, 2009, 1:17 PM EDT) -- A federal judge has scuttled pharmaceuticals giant Wyeth's request for an immediate temporary restraining order barring the U.S. Food and Drug Administration's approval for India-based Orchid Chemicals & Pharmaceuticals Ltd.'s generic version of Wyeth's intravenous antibiotic Zosyn.

Judge Ellen S. Huvelle of the U.S. District Court for the District of Columbia filed a minute order Sept. 23 denying Wyeth's injunctive request to immediately roll back the FDA's go-ahead on a generic Zosyn, which Wyeth alleged in a lawsuit filed the same day was not sufficiently similar...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.